Title: bluebird bio Announces Positive Phase 1/2 Clinical Trial Data for Gene Therapy
In recent financial reports submitted to the Securities and Exchange Committee (SEC) in an 8-K filing, bluebird bio, Inc. (NASDAQ: BLUE), a leading biotech company, has provided an update on their ...
Blue Bird Corporation: An Opportunity To Hitch A Ride To Strong Upside
Blue Bird Corporation is a compelling investment due to its focus on electric school buses and attractive stock valuation despite recent performance setbacks. Read more here.
Analysts Conflicted on These Consumer Cyclical Names: Blue Bird (BLBD) and Alibaba (BABA)
Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Blue Bird (BLBD – Research Report) and Alibaba (BABA ...
Bluebird Banter3 天
Wednesday Bantering: Nothing Much Going On
The first full squad workout was yesterday, so spring training is fully underway. There’s an actual game tomorrow, although ...
Why Blue Bird (BLBD) Remains a Solid Choice Despite Policy Uncertainty
Blue Bird Corporation (BLBD) recently announced fiscal Q1 results, beating top and bottom-line expectations. While the ...
B&T’s Campaigns Of The Month: Carlton Dry’s Mid-shirted Heroes Take On Bluebird’s ...
B&T reckons punters might need more than a mid-strength Carlton Dry after being exposed to some of these midriffs.
Blue Bird's SWOT analysis: stock soars on EV strategy, operational gains
Blue Bird Corporation (NASDAQ:BLBD), a leading manufacturer of school buses, has been making significant strides in the electric vehicle (EV) market while improving its operational efficiency.